1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Subcutaneous epcoritamab + R-DHAX/C in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) eligible for autologous stem cell transplant (ASCT): Preliminary phase 1/2 results
    Meeting Abstract

    Abrisqueta, P.; Falchi, L.; Phillips, T. J.; De Vos, S.; Nijland, M.; Offner, F.; Bykhovski, I.; Wu, J.; Wang, L.; Rana, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of a novel radiohapten capture system in car T cells for tracking in vivo and improving CAR T efficacy
    Meeting Abstract

    Kurtz, K.; Dacek, M.; Cheal, S.; Veach, D.; Qureshy, S.; Carter, L.; Eibler, L.; Verma, S.; McDevitt, M.; Punzalan, B.; more...
    Human Gene Therapy (2022)

    Fulltext@MSK | Save
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30
    Meeting Abstract

    Gerlach, M.; Schmitt, S.; Cyprys, P.; Kasper, M. A.; Mai, I.; Vermeer, M. H.; Horwitz, S. M.; Fingerle-Rowson, G.; Vogl, A.; Schumacher, D.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • The COBALT-LYM study of CTX130: A phase 1 dose escalation study of CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T cells in patients with relapsed/refractory (R/R) T-cell malignancies
    Meeting Abstract

    Zain, D. R.; Iyer, S. P.; Sica, R. A.; Ho, P. J.; Hu, B.; Prica, A.; Weng, W. K.; Kim, Y. H.; Khodadoust, M. S.; Palomba, M. L.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4])
    Meeting Abstract

    Lunt, C.; D'Angelo, S. P.; Razak, A. R. A.; Wagner, M. J.; Van Tine, B. A.; Ganjoo, K.; Blay, J. Y.; Araujo, D. M.; Agulnik, M.; Glod, J. W.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Excellent 3-year survival in recipients of mismatched unrelated donor transplants using post-transplant cyclophosphamide: Longer term outcomes of a national marrow donor program-sponsored prospective clinical trial
    Meeting Abstract

    Shaw, B.; Jimenez-Jimenez, A. M.; Burns, L.; Logan, B.; Khimani, F.; Shaffer, B.; Shah, N.; Mussetter, A.; Tang, X. Y.; McCarty, J.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Toward improving diagnostic criteria for TA-TMA: Interim analysis of a multi-center retrospective review by the TA-TMA Working Group
    Meeting Abstract

    Rondon, G.; Giralt, S.; Boelens, J. J.; Cairo, M. S.; Champlin, R.; Duarte, R. F.; Hamadani, M.; Higham, C.; Ho, V. T.; Jerkins, J. H.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation (alloHCT) in anaplastic large cell lymphoma (ALCL)
    Meeting Abstract

    Hamadani, M.; Chen, Y.; Kharfan-Dabaja, M.; Herrera, A.; Sauter, C.; Ahn, K.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • A phase 2 study of itacitinib for the prevention of cytokine release syndrome (CRS) induced by immune effector cell (IEC) therapy: Preliminary results
    Meeting Abstract

    Frigault, M. J.; Maziarz, R. T.; Lazaryan, A.; Frey, N. V.; Assal, A.; Shah, N. N.; Lekakis, L. J.; Park, J. H.; Phillips, C. L.; Burke, L.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save